Radiating Positivity: Roche’s Actemra Sees More Positive Results In Third Pivotal Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
After announcing positive results from its RADIATE study, Roche awaits monotherapy study results to determine whether to file as first-line treatment, firm tells “The Pink Sheet” DAILY.